CYP4V3 Inhibitors constitute a specific class of chemical compounds designed to selectively obstruct the activity of the CYP4V3 enzyme. CYP4V3, or Cytochrome P450 4V3, belongs to the larger cytochrome P450 superfamily, a diverse group of enzymes involved in the metabolism of various endogenous and exogenous compounds. The development of inhibitors targeting CYP4V3 serves as a critical tool for scientific investigation, providing researchers with a means to unravel the molecular functions and metabolic processes associated with this particular enzyme. As a member of the cytochrome P450 family, CYP4V3 is likely engaged in the oxidative metabolism of lipids or xenobiotics, contributing to the intricate regulation of cellular lipid homeostasis and detoxification processes.
The synthesis and optimization of CYP4V3 inhibitors demand a nuanced understanding of the enzyme's structural characteristics and its intricate interactions within cellular pathways. These inhibitors are intricately designed for specificity, with the objective of selectively binding to essential regions of CYP4V3 and disrupting its normal catalytic activities. By employing CYP4V3 inhibitors in experimental settings, researchers can delve into the consequences of enzyme inhibition on lipid metabolism, shedding light on the specific substrates and metabolic pathways governed by CYP4V3. The study of CYP4V3 inhibitors contributes to the broader comprehension of cytochrome P450-mediated metabolism, offering insights into the intricate molecular machinery that underlies the biotransformation of lipids and xenobiotics in cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, inhibiting transcription and preventing the synthesis of CYP4V3 mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide disrupts protein synthesis, leading to a reduction in CYP4V3 expression by inhibiting translation. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin induces premature termination of protein synthesis, impacting translation and lowering CYP4V3 levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, indirectly suppressing CYP4V3 expression by interfering with transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin hinders protein synthesis by blocking peptidyl transferase activity, leading to reduced CYP4V3 synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin interferes with mRNA synthesis, impacting transcription and contributing to the downregulation of CYP4V3. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting CYP4V3 expression by disrupting purine synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing CYP4V3 levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil interferes with RNA synthesis, affecting the expression of CYP4V3 by disrupting the production of mRNA. | ||||||